Clinical trial
Controlled Arterial Protection to Ultimately Remove Embolic Material
NCT06103591 is registered in ClinicalTrials.gov with EmStop Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Controlled Arterial Protection to Ultimately Remove Embolic Material
- Lead sponsor
- EmStop Inc
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 27, 2023
- Completion date
- October 14, 2024
- Enrollment
- 15 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.